Alexza Pharmaceuticals, Inc. reported today financial results for the fourth quarter and year ended December 31, 2009 and provided a general corporate update. Â The net loss for the quarter and year ended December 31, 2009, as reported in accordance with accounting principles generally accepted in the United States , was $19.8 million and $56.1 million, respectively, compared to a net loss of ...

[News Source]